Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies()

Metronomic chemotherapy (MET) has been developed to address the shortcomings of maximum-tolerated chemotherapy (MTD) in regard to toxicity and development of resistance mechanisms in the tumor. In colorectal cancer (CRC), MET is a promising novel strategy to treat locally advanced malignancies when...

Descripción completa

Detalles Bibliográficos
Autores principales: Mundo, Ariel I., Muhammad, Abdussaboor, Balza, Kerlin, Nelson, Christopher E., Muldoon, Timothy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326335/
https://www.ncbi.nlm.nih.gov/pubmed/35901621
http://dx.doi.org/10.1016/j.neo.2022.100825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326335/
https://www.ncbi.nlm.nih.gov/pubmed/35901621
http://dx.doi.org/10.1016/j.neo.2022.100825

Ejemplares similares